BACKGROUND: The prevalence of medication errors associated with chemotherapy administration is not precisely known. Little evidence exists concerning the extent or nature of errors; however, some evidence demonstrates that errors are related to prescribing. This article demonstrates how the review of chemotherapy orders by a designated nurse known as a verification nurse (VN) at a National Cancer Institute-designated comprehensive cancer center helps to identify prescribing errors that may prevent chemotherapy administration mistakes and improve patient safety in outpatient infusion units. OBJECTIVES: This article will describe the role of the VN and details of the verification process. METHODS: To identify benefits of the VN role, a retrospective review and analysis of chemotherapy near-miss events from 2009-2014 was performed. FINDINGS: A total of 4,282 events related to chemotherapy were entered into the Reporting to Improve Safety and Quality system. A majority of the events were categorized as near-miss events, or those that, because of chance, did not result in patient injury, and were identified at the point of prescribing.
BACKGROUND: The prevalence of medication errors associated with chemotherapy administration is not precisely known. Little evidence exists concerning the extent or nature of errors; however, some evidence demonstrates that errors are related to prescribing. This article demonstrates how the review of chemotherapy orders by a designated nurse known as a verification nurse (VN) at a National Cancer Institute-designated comprehensive cancer center helps to identify prescribing errors that may prevent chemotherapy administration mistakes and improve patient safety in outpatient infusion units. OBJECTIVES: This article will describe the role of the VN and details of the verification process. METHODS: To identify benefits of the VN role, a retrospective review and analysis of chemotherapy near-miss events from 2009-2014 was performed. FINDINGS: A total of 4,282 events related to chemotherapy were entered into the Reporting to Improve Safety and Quality system. A majority of the events were categorized as near-miss events, or those that, because of chance, did not result in patient injury, and were identified at the point of prescribing.
Authors: Tejal K Gandhi; Saul N Weingart; Andrew C Seger; Joshua Borus; Elisabeth Burdick; Eric G Poon; Lucian L Leape; David W Bates Journal: J Gen Intern Med Date: 2005-09 Impact factor: 5.128
Authors: Pascal Bonnabry; Laurence Cingria; Monique Ackermann; Farshid Sadeghipour; Lucienne Bigler; Nicolas Mach Journal: Int J Qual Health Care Date: 2005-11-07 Impact factor: 2.038
Authors: Tejal K Gandhi; Sylvia B Bartel; Lawrence N Shulman; Deborah Verrier; Elisabeth Burdick; Angela Cleary; Jeffrey M Rothschild; Lucian L Leape; David W Bates Journal: Cancer Date: 2005-12-01 Impact factor: 6.860
Authors: Joseph O Jacobson; Martha Polovich; Terry R Gilmore; Lisa Schulmeister; Peg Esper; Kristine B Lefebvre; Michael N Neuss Journal: J Oncol Pract Date: 2011-12-13 Impact factor: 3.840
Authors: Kathleen E Walsh; Katherine S Dodd; Kala Seetharaman; Douglas W Roblin; Lisa J Herrinton; Ann Von Worley; G Naheed Usmani; David Baer; Jerry H Gurwitz Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544